Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CEBPD |
| Upstream (Parents) |
|---|
| (<<) BLNK → CEBPD |
| (<<) CXCL2 → CEBPD |
| (<<) FNDC4 → CEBPD |
| (<<) GPX3 → CEBPD |
| (<<) HGS → CEBPD |
| (<<) HSD17B2 → CEBPD |
| (<<) HYAL1 → CEBPD |
| (<<) MT1F → CEBPD |
| (<<) NNMT → CEBPD |
| (<<) NRG1 → CEBPD |
| (<<) RDH16 → CEBPD |
| (<<) ST3GAL6 → CEBPD |
| (<<) TFPI2 → CEBPD |
| (<<) YWHAB → CEBPD |
| Downstream (Children) |
|---|
| CEBPD → CAT (>>) |
| CEBPD → CYP2U1 (>>) |
| CEBPD → DDR1 (>>) |
| CEBPD → DUSP10 (>>) |
| CEBPD → EPHB2 (>>) |
| CEBPD → EVX1 (>>) |
| CEBPD → FKSG2 (>>) |
| CEBPD → G0S2 (>>) |
| CEBPD → INSR (>>) |
| CEBPD → PIK3C2B (>>) |
| CEBPD → PLA2R1 (>>) |
| CEBPD → PLCG2 (>>) |
| CEBPD → RNF111 (>>) |
| CEBPD → TSG101 (>>) |
